Global Liquid Biopsy Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Liquid Biopsy Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Liquid biopsy technology is a non-invasive diagnostic approach that involves the analysis of biomarkers and genetic material (such as circulating tumor DNA or ctDNA) present in body fluids, primarily blood, to detect and monitor various diseases, especially cancer. Unlike traditional biopsies that involve invasive procedures to collect tissue samples, liquid biopsy offers a less invasive and potentially more convenient method for disease detection and monitoring.
Liquid Biopsy Technology report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liquid Biopsy Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Blood Sample and Urine Sample are the major drivers for the industry.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Liquid Biopsy Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Segment by Type
CTCs
ctDNA
Exosomes
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liquid Biopsy Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Liquid Biopsy Technology introduction, etc. Liquid Biopsy Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Liquid Biopsy Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Liquid Biopsy Technology report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liquid Biopsy Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Blood Sample and Urine Sample are the major drivers for the industry.
The global market for liquid biopsy technology has been experiencing substantial growth in recent years, driven by the increasing prevalence of cancer and other chronic diseases, the demand for non-invasive diagnostic methods, and advancements in genomic research and personalized medicine. The demand for liquid biopsy technology varies across different regions, with key markets located in North America, Europe, Asia-Pacific, and other regions with a high burden of cancer and robust research infrastructure. North America, including the United States and Canada, has been a dominant market for liquid biopsy technology due to the presence of well-established healthcare systems, high incidence of cancer, and strong investment in medical research. The global market for liquid biopsy technology is expected to continue growing in the coming years, driven by ongoing advancements in genomic research, increasing adoption of personalized medicine, and the need for non-invasive diagnostic solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Liquid Biopsy Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Exact Sciences
Guardant Health
Natera
Bio-Techne
LabCorp
Endress+Hauser
MDxHealth
MutantDx
Thermo Fisher Scientific
Norgen Biotek
Nucleix
OraSure Technologies
Qiagen
Bio-Rad Laboratories
Biocartis
NeoGenomics
Sysmex Inostics
Menarini Silicon Biosystems
Biocept
ANGLE plc
Segment by Type
CTCs
ctDNA
Exosomes
Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liquid Biopsy Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Liquid Biopsy Technology introduction, etc. Liquid Biopsy Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Liquid Biopsy Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices